naringenin and Acute Myelogenous Leukemia

naringenin has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Du, X; Li, M; Lou, J; Shi, D; Xu, Y; Zhang, X; Zhuo, J1

Other Studies

1 other study(ies) available for naringenin and Acute Myelogenous Leukemia

ArticleYear
Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways.
    Molecular medicine reports, 2015, Volume: 12, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Curcumin; Extracellular Signal-Regulated MAP Kinases; Flavanones; Humans; Leukemia, Myeloid, Acute; MAP Kinase Kinase 4; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Suppressor Protein p53

2015